Analgesics (Pharmacies) - Western Africa

  • Western Africa
  • Revenue in the Analgesics market is projected to reach US$0.34bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 9.69%, resulting in a market volume of US$0.54bn by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.81 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Western Africa is experiencing steady growth and development, driven by various factors that are shaping customer preferences and market trends in the region. Customer preferences in the Analgesics (Pharmacies) market in Western Africa are influenced by several factors. Firstly, there is a growing awareness and demand for over-the-counter pain relief medications among the population. As people become more health-conscious and seek quick relief from common ailments such as headaches, muscle pain, and fever, the demand for analgesics in pharmacies has increased. Additionally, the convenience of purchasing these medications from pharmacies, which are easily accessible and offer a wide range of products, is also a key factor driving customer preferences. Trends in the market indicate a shift towards the use of generic analgesics in Western Africa. Generic medications are more affordable and offer similar efficacy to branded products, making them a popular choice among price-sensitive consumers. This trend is further fueled by the availability of generic analgesics in pharmacies, which often stock a variety of generic options to cater to different customer needs. Furthermore, the increasing competition among pharmaceutical companies has led to the introduction of new and innovative analgesic products in the market, providing customers with a wider range of options to choose from. Local special circumstances in Western Africa also play a role in shaping the Analgesics (Pharmacies) market. The region has a high prevalence of infectious diseases, such as malaria and typhoid, which often result in fevers and body aches. This drives the demand for analgesics in pharmacies, as people seek relief from these symptoms. Additionally, the region's diverse population and cultural practices influence the types of analgesics preferred by customers. Traditional remedies and herbal medicines are still popular among certain segments of the population, leading to a demand for analgesics that incorporate natural ingredients. Underlying macroeconomic factors contribute to the development of the Analgesics (Pharmacies) market in Western Africa. Economic growth and rising disposable incomes have increased the purchasing power of consumers, enabling them to afford analgesics and other healthcare products. Additionally, improvements in healthcare infrastructure and access to pharmacies have made it easier for customers to obtain analgesics. The region's population growth and urbanization also contribute to the growing demand for analgesics, as urban areas tend to have a higher concentration of pharmacies and a larger customer base. In conclusion, the Analgesics (Pharmacies) market in Western Africa is witnessing growth and development driven by customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing awareness and demand for over-the-counter pain relief medications, the shift towards generic analgesics, and the availability of a wide range of products in pharmacies are all contributing to the market's growth. Furthermore, the region's high prevalence of infectious diseases, cultural practices, and improving healthcare infrastructure are shaping customer preferences and driving the demand for analgesics in pharmacies.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)